Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Johnson and Johnson
AstraZeneca
Merck
McKesson

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Norethindrone And Ethinyl Estradiol And Ferrous Fumarate patents expire, and when can generic versions of Norethindrone And Ethinyl Estradiol And Ferrous Fumarate launch?

Norethindrone And Ethinyl Estradiol And Ferrous Fumarate is a drug marketed by Accord Hlthcare, Amneal Pharms, Apil, Barr, Lupin Ltd, and Mylan Labs Ltd. and is included in seven NDAs. There is one patent protecting this drug.

The generic ingredient in NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

Drug patent expirations by year for NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
Recent Clinical Trials for NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Teva Pharmaceuticals USAPhase 1

See all NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE clinical trials

Recent Litigation for NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

Identify potential future generic entrants

District Court Litigation
Case NameDate
Teva Women's Health, Inc. v. Famy Care Ltd.2014-12-05
Warner Chilcott Company, LLC v. Lupin Ltd.2014-01-27
Bayer Intellectual Property GMBH v. Warner Chilcott Company LLC2012-08-13

See all NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE litigation

US Patents and Regulatory Information for NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone TABLET, CHEWABLE;ORAL 207066-001 Mar 29, 2017 AB RX No No   See Pricing   See Pricing   See Pricing
Mylan Labs Ltd NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone TABLET, CHEWABLE;ORAL 202086-001 Apr 1, 2015 AB RX No Yes   See Pricing   See Pricing   See Pricing
Barr NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone TABLET, CHEWABLE;ORAL 078965-001 Aug 5, 2010 AB RX No No   See Pricing   See Pricing   See Pricing
Amneal Pharms NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone TABLET, CHEWABLE;ORAL 078892-001 Sep 26, 2011 AB RX No No   See Pricing   See Pricing   See Pricing
Apil NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone TABLET, CHEWABLE;ORAL 022573-001 Dec 22, 2010 AB RX Yes Yes   See Pricing   See Pricing Y   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apil NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone TABLET, CHEWABLE;ORAL 022573-001 Dec 22, 2010   See Pricing   See Pricing
Apil NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone TABLET, CHEWABLE;ORAL 022573-001 Dec 22, 2010   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Merck
Colorcon
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.